A.R.T. Advisors’s Endologix Inc ELGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-3,316
Closed -$63K 1866
2018
Q3
$63K Buy
3,316
+1,653
+99% +$59K ﹤0.01% 1308
2018
Q2
$94K Buy
+1,663
New +$84.4K ﹤0.01% 1296
2018
Q1
Sell
-1,240
Closed -$66K 1914
2017
Q4
$66K Sell
1,240
-15,979
-93% -$844K ﹤0.01% 1282
2017
Q3
$767K Buy
17,219
+1,040
+6% +$47.4K 0.04% 660
2017
Q2
$786K Buy
16,179
+8,969
+124% +$528K 0.04% 622
2017
Q1
$522K Buy
+7,210
New +$477K 0.02% 793
2016
Q1
Sell
-19,711
Closed -$1.95M 1804
2015
Q4
$1.95M Buy
+19,711
New +$2.11M 0.09% 301
2015
Q2
Sell
-1,156
Closed -$197K 1837
2015
Q1
$197K Buy
+1,156
New +$175K 0.01% 1235
2014
Q2
Sell
-2,257
Closed -$290K 1654
2014
Q1
$290K Sell
2,257
-3,029
-57% -$471K 0.02% 993
2013
Q4
$921K Buy
5,286
+1,595
+43% +$274K 0.05% 511
2013
Q3
$595K Sell
3,691
-981
-21% -$154K 0.03% 705
2013
Q2
$620K Buy
+4,672
New +$660K 0.02% 794

Other funds holding ELGX

A.R.T. Advisors's ELGX Position: Q4 2018 in Review

A.R.T. Advisors sold out of Endologix Inc (ELGX) in Q4 2018, closing a stake of 3,316 shares — an estimated $63K sold.

A.R.T. Advisors first reported a position in ELGX in Q2 2013 and held it in 12 quarters. The position peaked at $1.95M in Q4 2015. 99 funds tracked by Wall St. Rank hold ELGX as of Q4 2018.

  • A.R.T. Advisors reported no remaining Endologix Inc position as of Q4 2018 after selling out during the quarter.
  • A.R.T. Advisors sold 3,316 Endologix Inc shares in Q4 2018, an estimated $63K.
  • A.R.T. Advisors first reported a position in Endologix Inc in Q2 2013 and held it in 12 quarters.
  • A.R.T. Advisors's Endologix Inc position peaked at $1.95M in Q4 2015.
  • 99 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2018.

Based on A.R.T. Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.